[go: up one dir, main page]

AR055807A1 - Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina - Google Patents

Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina

Info

Publication number
AR055807A1
AR055807A1 ARP060105511A ARP060105511A AR055807A1 AR 055807 A1 AR055807 A1 AR 055807A1 AR P060105511 A ARP060105511 A AR P060105511A AR P060105511 A ARP060105511 A AR P060105511A AR 055807 A1 AR055807 A1 AR 055807A1
Authority
AR
Argentina
Prior art keywords
combination
clonixinate
dichlofenaco
lisine
pharmaceutical composition
Prior art date
Application number
ARP060105511A
Other languages
English (en)
Inventor
Sanchez Carmen Miguel Gomez
Suarez Graciela De Lo Aguilera
Lora Martha Rosaura Juarez
Original Assignee
Farmaceuticos Rayere S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38287864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR055807(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmaceuticos Rayere S A filed Critical Farmaceuticos Rayere S A
Publication of AR055807A1 publication Critical patent/AR055807A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a la combinacion de dos fármacos analgésicos antiinflamatorios no esteroides los cuales son el diclofenaco con accion antiinflamatoria predominante y el clonixinato de lisina con accion analgésica predominante. La combinacion es formulada en un solo medicamento en las formas farmacéuticas oral e inyectable, cuando se combinan ambos fármacos en proporciones específicas la combinacion produce efectos farmacologicos de analgesia que indican una superactividad (sinergia). El perfil favorable de efectos adversos que se observa después de la administracion de la combinacion sugiere que esta estrategia terapéutica puede ser una herramienta promisoria en el alivio del dolor agudo moderado a severo.
ARP060105511A 2006-01-19 2006-12-14 Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina AR055807A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000005 WO2007083985A1 (es) 2006-01-19 2006-01-19 Composición farmacéutica sinergística de diclofenaco y clonixinato de lisina

Publications (1)

Publication Number Publication Date
AR055807A1 true AR055807A1 (es) 2007-09-12

Family

ID=38287864

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105511A AR055807A1 (es) 2006-01-19 2006-12-14 Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina

Country Status (2)

Country Link
AR (1) AR055807A1 (es)
WO (1) WO2007083985A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX351622B (es) * 2013-05-27 2017-10-17 Farm Rayere S A Composicion farmaceutica sinergistica de dos analgesicos con distinto perfil farmacocinetico.
CA2951987C (en) 2014-06-16 2017-10-24 Farmaceuticos Rayere, S.A. Pharmaceutical composition that combines an anticonvulsant and a nicotinic acid derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
FR2262967B1 (es) * 1974-03-07 1977-11-04 Roemmers Sa Ind Comercial
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.

Also Published As

Publication number Publication date
WO2007083985A1 (es) 2007-07-26

Similar Documents

Publication Publication Date Title
MX2009005339A (es) Suspensiones analgesicas de liberacion modificada.
ECSP17013617A (es) “combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid”
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
AR082167A1 (es) Formas de dosificacion gastrorretentivas
PL2043637T3 (pl) Sposoby i leki do podawania ibuprofenu
ECSP099348A (es) Composición farmacéutica de liberación modificada de un músculo relajante y un aine
AR077284A1 (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
CY1118263T1 (el) Φλουρμπιπροφαινη ελεγχομενης εκλυσης και μυοχαλαρωτικοι συνδιασμοι
PE20040973A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
AR065917A1 (es) Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor
AR055807A1 (es) Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina
ECSP10010054A (es) Composiciones farmacéuticas que comprenden la combinación de un agente antiinflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa útiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas
CO6331430A2 (es) Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia
DOP2010000265A (es) Formulacion galenica oral que comprende ketorolaco y vitaminas del complejo b, en la que la vitamina b6 se encuentra em una capa externa separada del resto de principios activos
MX2010012836A (es) Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos.
ZA202305383B (en) Topical administration of 2- (diethylamino) ethyl 2- (4-isobutylphenyl) propionate for treatment of diseases
ECSP099649A (es) Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor
AR048958A1 (es) Medicamento en forma de pelicula para administracion por via oral, que contiene estriol
GT200700005A (es) Composicion farmaceutica estable de carisoprodol y meloxicam
AR060205A1 (es) Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina
AR061046A1 (es) Mirtazapina para el tratamiento del dolor neuropatico
PE20160038A1 (es) Composicion farmaceutica sinergistica de dos analgesicos con distinto perfil farmacocinetico

Legal Events

Date Code Title Description
FB Suspension of granting procedure